LYNDA CHIN was named a recipient of the Chancellor's Health Fellowship by MD Anderson Cancer Center.
On the fifth anniversary of the landmark 2009 law granting the FDA authority over tobacco products, 10 leading public health and medical organizations called on the FDA and the Obama Administration to prioritize three actions to reduce tobacco use.
FDA approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent, to determine the extent squamous cell carcinoma has spread in the body's head and neck region.
Grants and Intramural Program ReviewCouple of things about grants; everyone wants to know what's happening with grants.
Varmus's Joint BSA-NCAB Meeting Remarks - June 23, 2014.NCI has received some relief from sequestration, and the budget cuts will be adjusted proportionally, Director Harold Varmus said at the joint meeting of the National Cancer Advisory Board and the Board of Scientific Advisors June 23.
ODAC member Brent Logan, professor of biostatistics at the Medical College of Wisconsin, said he didn't have confidence in the PFS advantage seen in Study 19.
Some of the questions that landed the AstraZeneca drug Olaparib (lynparza) before the FDA Oncologic Drugs Advisory Committee were classic:
BAYER PHARMA AG and arGEN-X announced a collaboration to develop therapeutic antibodies.
ELI LILLY AND COMPANY and Qiagen N.V. announced a plan to co-develop universal and modular assay panels for the simultaneous analysis of DNA and RNA biomarkers targeting multiple cellular pathways involved in common cancer types.
DANA-FARBER CANCER INSTITUTE and Trovagene Inc. entered into a clinical collaboration to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.
